<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>AMA Publishing Group: Sexually Transmitted Diseases (not HIV/AIDS) Topic Collection</title>
    <link>http://pubs.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Mon, 13 May 2013 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 14 May 2013 18:47:03 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@pubs.jamanetwork.com</managingEditor>
    <webMaster>webmaster@pubs.jamanetwork.com</webMaster>
    <item>
      <title>Adult Mortality in a Randomized Trial of Mass Azithromycin for Trachoma</title>
      <link>http://pubs.jamanetwork.com/article.aspx?articleID=1673751</link>
      <pubDate>Mon, 13 May 2013 00:00:00 GMT</pubDate>
      <author>Keenan JD, Emerson PM, Gaynor BD, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;Annual mass azithromycin treatments are provided to entire communities to clear the ocular strains of Chlamydiatrachomatis that cause blinding trachoma. Mass treatments reduce the community burden of ocular chlamydia and have proven efficacious in community-randomized trials. Since 1999, more than 150 million doses of azithromycin have been distributed for trachoma worldwide.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">173</prism:volume>
      <prism:number xmlns:prism="prism">9</prism:number>
      <prism:startingPage xmlns:prism="prism">821</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">823</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jamainternmed.2013.3041</prism:doi>
      <guid>http://pubs.jamanetwork.com/article.aspx?articleID=1673751</guid>
    </item>
  </channel>
</rss>